Halozyme Therapeutics Inc (NASDAQ:HALO)

15.76
BATS BZX Real-Time Price
As of 10:17am ET
 +0.06 / +0.38%
Today’s Change
6.88
Today|||52-Week Range
15.94
+63.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-53.2M-19.8M-53.6M-83.5M
 
 
 
 
 
Depreciation1.5M1.1M1.1M1.2M
 
 
 
 
 
Total Other Cash Flow4.9M5.6M8.4M10.8M
 
 
 
 
 
Funds From Operations-46.9M-13.1M-44.1M-71.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.5M21.2M20.2M-22.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-45.4M-34.4M-64.3M-49.2M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-48.9M
 
 
Decrease In Investments0.000.000.003.4M
 
 
Capital Expenditures-646.5K-828.5K-1.4M-2.3M
 
 
 
 
 
Net Cash Flow Investing-646.5K-828.5K-1.4M-47.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.0029.7M20.0M
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale61.8M4.7M83.2M5.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing61.8M4.7M112.8M25.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash15.8M-30.4M47.1M-72.0M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account